Why Clarus Therapeutics Shares Are Getting Hammered
Clarus Therapeutics Holdings Inc (NASDAQ: CRXT) shares are trading lower by 52.82% at $0.85 after the company announced an upsized $30 million underwritten public offering at $1.10 per share.
Benzinga ·
Benzinga
